Chips

TTM Technologies bought $100 million of itself at $86.31 and its CEO followed at $88

TTM posted a record quarter, admitted its AI data-center line ran 10% below its own target, and watched the stock lose 63% from its high. Then the company spent $100 million buying itself at $86.31 and two insiders added $1.34 million at $88 to $90.

Vincent JiangVincent Jiang · 3 min read
Share
Edwin Roks, president and chief executive of TTM Technologies
1 / 6Slide 1 of 6
TTM Technologies CEO Edwin Roks bought $440,349 of his company's stock at $88.07 on October 28, two days after the company spent $100 million buying itself at $86.31.

The CEO bought two days after the company did

Edwin Roks, president and chief executive of TTM Technologies−4.83% — TTM Technologies, down 4.83 percent today, bought 5,000 shares of his own company at $88.07 on October 28, 2026, a $440,349 purchase that lifted his direct stake to 64,483 shares 2. The same day, director Wajid Ali bought 10,000 shares at an average $90.25, $902,460, taking his stake up 39% to 35,835 shares 3.

Two days before both filings, the company itself bought roughly 1.16 million of its own shares for $100 million at an average $86.31, every share of it on October 26 and 27 1. The board then authorized a fresh $100 million program running through October 27, 2027 1.

A record quarter, sold like a broken one

On October 22 TTM reported third-quarter revenue of $1.20 billion, up 59.9% year over year, non-GAAP earnings of $1.46 a share against a $1.25 consensus, and record adjusted EBITDA of $242.3 million at a 20.1% margin 4. The stock fell 23.8% in the morning session anyway, because the fourth-quarter revenue guide of $1.42 billion to $1.44 billion set its midpoint just under the $1.44 billion consensus 5. It opened October 30 at $82.94, down 63% from the 52-week high of $223.83 6.

The growth engine missed its own number

Data Center and Networking, 41% of quarterly sales, came in about 10% below the company's own guidance for the quarter 4. Roks told analysts the shortfall was customer program timing, not a technical problem, and that yields are where they should be, while lead times on materials run 12 weeks and sometimes 24 weeks or longer 4.

The cost of the growth plan is now on the page. Debt raised for the closed Epiq Solutions deal and the pending $650 million all-cash purchase of Ophir Optics adds roughly $20 million a quarter of interest, and fourth-quarter interest expense is guided to $33.9 million against $12.1 million in the third quarter 4.

Management bought between $86 and $90 while the average analyst target reads $173

  • Estimate
$0$50$100$150$200$250Average analyst target$173.2552-week high$223.83Open, Oct 30$82.94Buyback avg, Oct 26-27$86.31CEO buy, Oct 28$88.07Director buy, Oct 28$90.25
Data
Value
Average analyst target (estimate)$173.25
52-week high$223.83
Open, Oct 30$82.94
Buyback avg, Oct 26-27$86.31
CEO buy, Oct 28$88.07
Director buy, Oct 28$90.25
Share price levels in US dollars. Buyback average from TTM's October 27, 2026 8-K; CEO and director purchase prices from Form 4 filings dated October 28, 2026; open, average analyst target and 52-week high from MarketBeat, November 1, 2026. The analyst target is marked as an estimate.1,2,3,6

The shortage is real, and so is the doubt

The physical case for the business stands. Nikkei reports circuit-board orders taking up to 30 months to fill and at least one laminate supplier's order book filled through 2030 10.

The street's doubt stands too. Needham cut its target to $150 from $175, Stifel−2.44% — Stifel, down 2.44 percent today to $165 from $205 and Truist−1.40% — Truist, down 1.40 percent today to $170 from $231, all on October 23, yet the average target still reads $173.25 on a stock that opened at $82.94 76. Several law firms have announced investigations into possible securities-law violations after the selloff; those are allegations, not findings 9. And senior vice president Dale Knecht sold 26,198 shares at $142.00 in August, before the miss 9.

Three target cuts on October 23 still left an average target of $173 on an $83 stock

  • Old target
  • New target
$0$50$100$150$200$250Needham$150$175-14%Stifel$165$205-20%Truist$170$231-26%
Data
Old targetNew targetChange
Needham$175$150-14.3%
Stifel$205$165-19.5%
Truist$231$170-26.4%
Analyst price targets in US dollars before and after the October 23, 2026 cuts. From Ad hoc News (Needham) and MarketBeat; TTM opened October 30 at $82.94.7,6

What decides it

At $82.94 the stock trades near ten times the company's own preliminary 2027 earnings guide of $8.10 to $8.90 a share 46. The next reading is the fourth quarter itself, a $1.42 billion to $1.44 billion revenue guide now carrying $33.9 million of quarterly interest 4.

On the chart, the lines that matter are $102, the gap the stock fell from, and $80, the floor it held last week, with $55.44 as the 52-week low underneath 8. Management marked its position at $86 to $90 with real money 8. The street left its average target at $173 on an $83 stock, and the next quarterly print decides whose mark holds 8.

Get Chips by email, free

How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.

Loading TTMI

Reader comments

0 comments

    Chips

    Omni MedSci sued STMicroelectronics and Sony over nine depth-sensing patents as four banks cut targets

    On October 30, Omni MedSci sued STMicroelectronics and Sony over nine patents on near-infrared time-of-flight sensing, the same day four banks cut their targets on a quarter that beat. The claim lands on the layer ST pitches as its physical-AI future, and no damages figure exists to price it.

    Chips

    KLA says optical parts pace its shipments; Coherent and Lumentum report November 4 and 5

    KLA beat and guided higher, then told investors on the same call that optical parts pace its shipments and memory prices defer its margin recovery. Coherent reports November 4 and Lumentum November 5, and those two prints decide whether the constraint story holds.

    Chips

    MaxLinear says it will take 20% to 30% of Credo's next 1.6T cable market, and Credo reports in December

    Credo's copper cables run the AI data center floor and the stock has halved from its high. MaxLinear's chief executive has named his share target, and an early-December earnings report decides whose math holds.

    Chips

    Cohu's $1 billion AI pipeline has only $230 million qualified, and seven programs decide its 2027 guide

    Cohu printed its best AI quarter yet on October 28 and the market sold it anyway: only about $230 million of the $1 billion compute pipeline has cleared qualification, and the 2027 guide leans on the rest converting on a nine-month clock.

    Chips

    Astera Labs showed a 50-meter optical link and dated its optics for early 2027, before November 3 earnings

    Astera Labs demonstrated a live PCIe 6 link across 50 metres of fibre and dated its own optics for early 2027. The November 3 earnings report tests a switch business priced at 26 times this year's sales, so the Q4 guide decides whether that multiple stands.

    Chips

    Sequans' market cap is $12.5 million below the NYSE's $50 million line before November 3 results

    The French chipmaker raised $384 million to buy bitcoin, unwound the position by September, and now answers to the NYSE's market-cap rule before it answers to investors. Third-quarter results land on November 3.

    Get the newsletter

    The day's AI and market news, in your inbox every weekday.